Previous Close | 4.4900 |
Open | 4.5100 |
Bid | 4.5100 x 100 |
Ask | 4.5400 x 600 |
Day's Range | 4.4850 - 4.6450 |
52 Week Range | 3.8700 - 8.0500 |
Volume | |
Avg. Volume | 1,448,029 |
Market Cap | 1.326B |
Beta (5Y Monthly) | 0.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5100 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 15.38 |
Subscribe to Yahoo Finance Plus to view Fair Value for ABCL
In this article, we will take a detailed look at Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 11 Stocks. For a quick overview of such stocks, read our article Billionaire Investor Stan Druckenmiller and Insiders Are Piling Into These 5 Stocks. Billionaire Stanley Druckenmiller is one of the most revered investors in the Wall Street. […]
VANCOUVER, British Columbia, March 19, 2024--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time).
VANCOUVER, British Columbia, March 11, 2024--AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in neuroscience.